B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology

Cancer

Volumn 85, Issue 12, 1999, Pages 2648-2654

  Soslow, Robert A ^a   Baergen, Rebecca N ^a   Warnke, Roger A ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

B lineage; Blastoid variant of mantle cell lymphoma; Immunohistochemistry; Lymphoblastic lymphoma; Pathology; Prognostic factors

Indexed keywords

ASPARAGINASE; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; PROCARBAZINE; TENIPOSIDE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BONE MARROW; CANCER COMBINATION CHEMOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE; LYMPHOBLASTOMA; MALE; MANTLE CELL LYMPHOMA; MEDIASTINUM; PRIORITY JOURNAL; PROGNOSIS; SCHOOL CHILD; T CELL LYMPHOMA;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOMA, B-CELL; LYMPHOMA, LYMPHOBLASTIC; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0033564128     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19990615)85:12<2648::AID-CNCR22>3.0.CO;2-R     Document Type: Article

References (27)

1. Murphy S. Childhood non-Hodgkin's lymphoma. N Engl J Med 1978;299:1446-8.
2. Harris NL, Jaffe ES, Stein H. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994;84:1361-92.
3. Soslow RA, Bhargava V, Warnke RA. MIC2, TdT, bcl-2 and CD34 expression in paraffin-embedded high grade lymphoma/acute lymphoblastic leukemia distinguishes between distinct clinicopathologic entities. Hum Pathol 1997;28: 1158-65.
4. Soslow RA, Zukerberg LR, Harris NL, Warnke RA. BCL1 (PRAD-1/Cyclin D-1) overexpression distinguishes blastoid variant of mantle cell lymphoma from B-lineage lymphoblastic lymphoma. Mod Pathol 1997;10:810-7.
5. Nathwani BN, Diamond LW, Winberg CD, et al. Lymphoblastic lymphoma: a clinicopathologic study of 95 patients. Cancer 1981;48:2347-57.
6. Nathwani, Kim H, Rappaport H. Malignant lymphoma, lymphoblastic, Cancer 1976;38:964-83.
7. Coleman CN, Picozzi VJ Jr, Cox RS, McWhirter K, Weiss LM, Cohen JR, et al. Treatment of lymphoblastic lymphoma in adults. J Clin Oncol 1986;4:1628-37.
8. Zinzani PL, Bendandi M, Visani G, Gherlinzoni F, Frezza G, Merla E, et al. Adult lymphoblastic lymphoma: clinical features and prognostic factors in 53 patients. Leuk Lymphoma 1996;23:577-82.
9. Levine AM, Forman ST, Meyer DR. Successful therapy of convoluted T-lymphocyte lymphoma in the adult. Blood 61,92-8,1982
10. Morel P, Lepage E, Brice P, Dupriez B, D'Agay MF, Fenaux P, et al. Prognosis and treatment of lymphoblastic lymphoma in adults: a report on 80 patients J Clin Oncol 1992;10:1078-85.
11. Picozzi VJ, Coleman CN. Lymphoblastic lymphoma. Semin Oncol 1990;17:96-103.
12. Slater DE, Mertelsmann R, Koziner B, et al. Lymphoblastic lymphoma in adults. J Clin Oncol 1986;4:57-67.
13. Lardelli P, Bookman MA, Sundeen J, Longo DL, Jaffe ES. Lymphocytic lymphoma of intermediate differentiation. Am J Surg Pathol 1990;14:752-763.
14. Pittaluga S, Wlodarska I, Stul MS, Thomas J, Verhoef G, Cassiman JJ, et al. Mantle cell lymphoma: a clinicopathological study of 55 cases. Histopathology 1995;26:17-24.
15. Norton A, Matthews J, Pappa V, Shamash J, Love S, Rohatiner AZ, et al. Mantle cell lymphoma: natural history defined in a serially biopsied population over a 20 year period. Ann Oncol (Netherlands) 1995;6:249-256.
16. Cheng A, Su I, Wang H, Chen Y, Wang C. Characteristic clinicopathologic features of adult B-cell lymphoblastic lymphoma with special emphasis on differential diagnosis with an atypical form probably of blastic lymphocytic lymphoma of intermediate differentiation origin. Cancer 1994;73:706.
17. Decaudin D, Bosq J, Munck J, Bayle C, Koscielny S, Boudjemaa S, et al. Mantle cell lymphomas: Characteristics, natural history and prognostic factors of 45 cases. Leuk Lymphoma 1997;26:539-50.
18. Cossman J, Chused TM, Fisher RI, Magrath I, Bollum F, Jaffe ES. Diversity of immunological phenotypes of lymphoblastic lymphoma. Cancer Res 1983;43:4486-4490.
19. Grogan T, Spier C, Wirt DP, Hicks MJ, Paquin M, Hutter J, et al. Immunologic complexity of lymphoblastic lymphoma. Diagn Immunol 1986;4:81-88.
20. Link MP, Roper M, Dorfman RF, Crist WM, Cooper MD, Levy R. Cutaneous lymphoblastic lymphoma with pre-B markers. Blood 1983;61:838-841.
21. Sander CA, Medeiros LJ, Abruzzo LV, Horak ID, Jaffe ES. Lymphoblastic lymphoma presenting in cutaneous sites. J Am Acad Dermatol 1991;25:1023-1031.
22. Sander CA, Jaffe ES, Gebhardt FC, Yano T, Medeiros LJ. Mediastinal lymphoblastic lymphoma with an immature B-cell immunophenotype. Am J Surg Pathol 1992;16:300-305.
23. Sheibani K, Nathwani BN, Winberg CD, Burke JS, Swartz WG, Blayney D, et al. Antigenically defined subgroups of lymphoblastic lymphoma. Cancer 1987;60:183-190.
24. Weiss LM, Bindl JM, Picozzi VJ, Link MP, Warnke RA. Lymphoblastic lymphoma: an immunophenotype study of 26 cases with comparison to T cell acute lymphoblastic leukemia. Blood 1986;67:474-478.
25. Yeh KH, Cheng AL, Su IJ, Lin MT, Tien HF, Shen MC, et al. Prognostic significance of immunophenotypes in adult lymphoblastic lymphomas. Anticancer Res 1997;17:2269-72.
26. Rappaport H, Boiron M, DeVita VT Jr., et al. Report of the committee on Hodgkin's disease staging procedures. Cancer Res 1971;31:1862-3.
27. Ozdemirli M, Fanburg-Smith JC, Hartmann D-P, Shad AT, Lage JM, Magrath IT, et al. Precursor B-lymphoblastic lymphoma presenting as a solitary bone tumor and mimicking Ewing's sarcoma. Am J Surg Pathol 1998;22:795-804.